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Abstract
We consider the problem of constructing diffusion operators high dimensional data
X to address counterfactual functions F , such as individualized treatment effectiveness.
We propose and construct a new diffusion metric KF that captures both the local
geometry of X and the directions of variance of F . The resulting diffusion metric
is then used to define a localized filtration of F and answer counterfactual questions
pointwise, particularly in situations such as drug trials where an individual patient’s
outcomes cannot be studied long term both taking and not taking a medication. We
validate the model on synthetic and real world clinical trials, and create individualized
notions of benefit from treatment.
1 Introduction
We address the problem of building a metric on a high dimensional data set X = {xi} ⊂ Rd
that is smooth with respect to an external nonlinear function F . They types of functions
we consider arise from counterfactual questions, such as “would this patient benefit or be
hurt from medication, given their history and baseline health?”. In medical studies, these
functions adopt the interesting feature that they cannot be evaluated pointwise, since an
individual patient’s outcomes cannot be studied long term both taking and not taking a
medication.
Email: alexander.cloninger@yale.edu
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1.1 Mathematical Approach
In the case of an A/B treatment study, we denote the risk on treatment A as YA(x) and
treatment B as YB(x). The quantity YA(x)− YB(x) is known as the individual treatment
effectiveness. The treatment group is denoted TX = 1 if x is in treatment B, 0 otherwise. A
current method of dealing with treatment effectiveness is the Cox proportional hazard model
from [4]. In it, we let λ0(t) be the common baseline hazard function which describes the
risk of an outcome at each time step independent of treatment. Within treatment groups,
the hazard function for the Cox proportional hazard model takes the form
λ(t) = λ0(t)e
TXα+~βX ,
where TX ∈ {A,B} is an indicator function for which treatment patient x was in. This
makes the associated survival distribution
P (W ≥ w) = exp
[
−eXαY1(X)+(1−Xα)Y0(X)
∫ w
0
λ0(t)dt
]
.
Also assume there is a random censoring model, which means that people leave the trial at
random times throughout the process. This means we don’t observe the true outcome time
W of each patient, but instead we observe the leave time t = min(W,C), where C and W
are independent and C represents time to censorship. The indicator function D of whether
W ≤ C is known, as well.
A patient personalized version of this model would be
λ(t|x) = λ0(t|x)e(1−TX)YA(X)+TXYB(X),
which now allows the benefit or detriment of the drug to be patient specific.
In this model of personalized risk, YA and YB are unknowable pointwise in a drug trial
since each x only takes one of the drugs in {A,B}. So we estimate YB(X) − YA(X) in
a neighborhood by assuming that locally, patients satisfy a proportional hazard model,
with
λ0(t|z) ≈ λ0(t|x), YA(z) ≈ YA(x), YB(z) ≈ YB(x), for z ∈ N (x) = {z ∈ Rm : ρ(x, z) < },
for some metric ρ, which we discuss further in Section 3. Thus we can assume that everyone
in the neighborhood shares a common baseline risk, and the relative benefit of treatment
is a constant multiple of that risk. This allows us to run a cox proportional hazard model
on z ∈ N (x) by fitting α to
λ(t|z) = λ0(t)eαTZ , z ∈ N (x),
F (x) = α.
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Estimate of α for each neighborhood can be done in several ways. If we only observe D (i.e.
whether or not the patient had an outcome before leaving the trial), then α is estimated
through method of moments between the two treatment groups. If we observe the actual
outcome time t along with D, α is estimated through partial likelihood maximization. As a
note, while partial likelihood maximization uses more information and thus should result in
a better estimate, convergence guarantees are more difficult to derive. We present certain
guarantees for both approaches in Section 4.
This means F (x) reflects the amount a patient is positively or negatively affected by a
drug, and can be used to approximate YB(X) − YA(X). The problem turns into a metric
discovery problem of determining a metric ρ that learns the level sets of F . This is akin to
finding pockets of people, based only on baseline information X, that are at much higher
risk (or lower risk) on drug A than they are on drug B. Discovery of the metric ρ(x, y)
then allows for an analysis of “types” of responders and non-responders.
We view these types of functions F : X → R as functions that can only be evaluated
on large subsets of the data. In other words, F (E) for E ⊂ X is only computable when
|E| ≥ c > 0. We build an algorithm which constructs a metric ρ : X × X → R+ such
that
|F (E)− F (E′)| < Cρ(E,E′),
for a small constant C, where ρ(E,E′) = max{ρ(x, y) : x ∈ E, y ∈ E′}. In other words, the
metric ρ does not only consider the geometry of the space X, but also the geometry and
the properties of the function F being studied.
The purpose of computing ρ is two-fold:
1. this discovers the intrinsic organization of X which dictates changes in F . This makes
any subsequent clustering or analysis done using ρ reflect the level sets of F , as well as
the intrinsic structure of X. The reason for doing this is that F may not be smooth
with respect to the intrinsic geometry of the space, but has structure that is well
described by a subset of the features. Also,
2. this allows for simple estimation of F at a finer scale than it is reliable naively. Using
ρ, we are able to construct an estimate of F , which we call f̂ , which can be evaluated
pointwise via
f̂(x) = lim
→0
F (N d (x)), N

ρ (x) = {z ∈ Rm : ρ(x, z) < }.
One can also define a multi-scale decomposition of F via
f̂(x) =
∑
i
fi(x), f(x) = F (N
/2
d (x))− F (N d (x)).
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The key in both these approximations is that, provided F is smooth with respect
to ρ, the approximating −neighborhood will have a large radius about level sets of
F . This increases the number of points {xi} in N ρ (x) for a fixed , making the
approximations more accurate than those generated by taking an isotropic ball of
radius  about x.
1.2 Main Contributions
The study of individualized treatment effects has recently been considered with linear lasso
models of [12], and linear logistic models with AdaBoost of [8]. A number of models have
been built to predict outcomes from a single treatment, but high risk for an outcome does
not necessarily imply treatment benefit, as seen in [7, 6]. While these models provide
useful treatment recommendations, they project to a one dimensional function space and
interpretability is limited to the non-zero coefficients of the model.
While we are interested in determining a treatment recommendation, we are also interested
in the question of characterizing the level sets of a treatment effect. Diffusion embeddings
provide a non-linear framework to map out the data into a continuum of varying treatment
effectiveness. Using a diffusion metric, one can determine variability of types of patients
that similarly benefit from treatment (or lack of treatment).
Function regularized diffusion has been considered when F can be evaluated pointwise by
[14]. We have also previously examined building non-linear features of functions F that
cannot be evaluated pointwise and subsequently organize these features in [2], as well as
regression of non-linear Cox proportional hazard functions in [9].
The main contributions of this work are:
• the ability to build a function regularized diffusion metric without the ability to
evaluate F pointwise,
• interpolation of a function regularized diffusion metric to new points where F is
unknown, and
• the use of function regularized diffusion to define pockets of responders and non-
responders to a given treatment.
This paper is organized as follows. Section 2 gives background descriptions of the tools we
reference throughout the paper, including diffusion maps, and hierarchical cluster treesSec-
tion 3 details the function weighted trees used to generate ρ, as well as the introduces the
notion of estimating a data point’s personalized function estimate. Section 4 discusses the
guarantees that can be given for personalized treatment effect, as well as convergence rates.
Section 5 applies and validates our algorithm on several datasets of synthetic patients, and
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discovers the original ground truth metric. We also examine the algorithm on real world
patient data and examine validation schemes.
2 Background
In this section, we discuss previous research that considers organization of points. This
considers M ∈ Rn×m as a data matrix of n points and m features per point. Denote the
rows of M by X (the set of points), and the set of columns by Y (the set of features or
questions). For this section, there is no external function f being considered.
2.1 Diffusion Geometry
Diffusion maps is a manifold learning technique based on solving the heat equation on
a data graph, as in [3]. It has been used successfully in a number of signal processing,
machine learning, and data organization applications. We will briefly review the diffusion
maps construction.
Let X = {x1, ..., xn} be a high dimensional dataset with xi ∈ Rm. A data graph is con-
structed with each point xi as a node and edges between two nodes with weights k(xi, xj).
The affinity matrixKi,j = k(xi, xj) is required to be symmetric and non-negative. Common
choices of kernel are the gaussian
k(xi, xj) = e
− ‖xi−xj‖
2
2
2σ2 ,
or positive correlation
k(xi, xj) = max
( 〈xi, xj〉
‖xi‖‖xj‖ , 0
)
.
K can be computed using only nearest neighbors of xi such that k(xi, xj) ≥ τ > 0.
Let Di,i =
∑
j k(xi, xj). We normalize kernel K to create a Markov chain probability
transition matrix
P = D−1K.
The eigendecomposition of P yields a sequence of eigenpairs {(λi, φi)}n−1i=0 such that 1 =
λ0 ≥ λ1 ≥ ...
The diffusion distance dtDM (xi, xj) measures the distance between two points as the prob-
ability of points transitioning to a common neighborhood in some time t. This gives
dtDM (xi, xj) =
∑
xk∈X
(
P t(xi, xk)− P t(xj , xk)
)2
=
∑
k≥1
λ2tk (φ(xi)− φ(xj))2 .
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Retaining only the first d eigenvectors creates an embedding Φt : X → Rd such that
Φt : xi → [λt1φ1(xi), ..., λtdφd(xi)].
Figure 1 shows a two dimensional example dataset and the data graph generated on the
points. We also see the low frequency eigenfunctions on the data graph, and the diffusion
embedding Φt.
(a) Data Graph colored by x-coordinate (b) Data graph colored by φ1
(c) Data graph colored by φ2 (d) Φt colored by x-coordinate
Figure 1: Toy example to demonstrate relationship between geometry of dataset and eigen-
functions of graph. Dataset is only 2D for ease of visualization, algorithm is equally valid
on high-dimensional dataset.
Remark: The diffusion time t is a continuous variable, which can be thought of as the
degree to which Φt is a low-pass filter. For small t, more of the high-freqncy eigenfunctions
are given non-trivial weight. For large t, the embedding is mostly concentrated on the
low-frequency eigenfunctions that vary slowly across the data.
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2.2 Hierarchical Tree From Diffusion Distance
The main idea behind bigeometric organization is to construct a coupled geometry via a
partition tree on both the data points and the features. A partition tree is effectively a set
of increasingly refined partitions, in which finer child partitions (i.e. lower levels of the tree)
are splits of the parent folder which attempt to minimize the inter-folder variability.
Let X ⊂ Rm be a dataset of points, and Φt : X → Rd be a diffusion embedding with
corresponding diffusion distance dtDM : X ×X → R+. A partition tree on X is a sequence
of L tree levelsX `, 1 ≤ ` ≤ L. Each level ` consists of n(`) disjoint setsX `i such that
X =
n(`)⋃
i=1
X `i .
Also, we define subfolders (or children) of a setX `i to be the indices I
`+1
i ⊂ {1, ..., n(`+1)}
such that
X `i =
⋃
k∈I`+1i
X `+1k .
For notation, X 1 = X and X Li = {xi}. See Figure 2 for a visual breakdown of X.
This tree can be in two ways:
1. Top-down: Taking the embedded points Φt(X) ⊂ Rd, the initial split X 2 divides the
data into 2 (or k) clusters via k-means or some clustering algorithm. Each subsequent
folder is then split into 2 (or k) clusters in a similar way, until each folder contains a
singleton point.
2. Bottom-up: Taking the embedded points Φt(X) ⊂ Rd, the bottom folders X L−1 are
determined by choosing a fixed radius  and covering Φt(X) with balls of radius .
Each subsequent level of the tree is then generated as combinations of the children
nodes that are “closest” together under the distance dtDM .
Remark: It is important to note that whether one chooses a top-down or bottom-up
approach, the fact that the clustering occurs on the diffusion embedding Φt(X) makes the
resulting tree, by definition, a “bottom-up” geometry. This is because the embedding and
diffusion distance is built off of local similarities alone, meaning that the resultant geometry
and partition tree are based on properties of the underlying dataset and manifold rather
than the ambient dimension and a naive Euclidean distance in Rm.
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Figure 2: Breakdown of X into folders.
3 Weighted and Directional Trees Without Pointwise Func-
tion Evaluation
Let us denote our data space X ⊂ Rm. In its most general form, we have an external
function F : X → R which cannot be evaluated pointwise. F can only be evaluated on
large subsets E ⊂ X. We define the pointwise estimate of F to be f̂(x), as in (1). This is
done by defining a type of locally weighted distance to incorporate estimates of a feature’s
power to discriminate F in different half spaces. The details on this method are in Section
3.1. An overview of the approach is in Algorithm 1.
3.1 Weighted Trees
Let M ∈ Rn×m be the data matrix and F be the integral operator of interest. Denote the
rows of M by X (the set of points), and the set of columns by Y (the set of features or
questions). We wish to build feature weights on each folder of X that maximally separate
F . The algorithm is as follows:
1. Assume the tree X is known and separates X into hierarchical nodes. Fix a node
X `i .
2. For each element y ∈ Y , we split y into k intervals [aj , aj+1) and bin the elements of
X `i = {hj}kj=1 such that
x ∈ hj ⇐⇒ x(y) ∈ [aj , aj+1) and x ∈X `i .
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Algorithm 1 Calculate Function Weighted Metric
Required: Training points {xi}ni=1 ∈ Rm
Function F to be evaluated on E ⊂ Rm
Result: Φt : {xi}ni=1 → Rd such that range(f̂(x)) is large, where
f̂ : {xi}ni=1 → R
x 7→ F (N dtF (x))
1. Build a diffusion embedding of the points Φt(X) and a hierarchical tree X
2. Build a tree Y that determines the local coordinate feature weights (see Section 3.1)
3. Build a new diffusion embedding of the points Φt(X) and a hierarchical treeX based
on the kernel in (2)
4. Iterate between the points and the features until embedding Φt(X) and tree Y are
stable
5. Define pointwise neighborhood N 
dtF
(x) = {z ∈ Rm : ‖Φt(x) − Φt(z)‖2 < } and
function estimate f̂(x)
Question y is then assigned a local weight for its ability to discriminate F by
w`i (y) =
k∑
j=1
|hj |
|X `i |
· |F (hj)− F¯ |2, (1)
where F¯ is the weighted mean across all bins.
3. Now that every node of the tree X has local feature weights, we calculate the local
weights at a point xi by
wxi(y) =
∑
`
2−α`w`xi(y), where w
`
xi(y) = w
`
i (y) for xi ∈X `i .
These weights create a diagonal matrix Wxi where Wxi [y, y] = (wxi(y) + λ)−1 for a
small positive constant λ.
4. The kernel function k : X ×X → R+ is then
k(xi, xj) =
e−(xi−xj)
ᵀ(Wxi+Wxj )
−1(xi−xj)/σ2√
det(Wxi +Wxj )
. (2)
The normalization in the denominator is needed to guarantee k is positive semi-
definite.
Theorem 1. The kernel k : X ×X → R+ from (2) is positive semi-definite.
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The proof of Theorem 1 is in Appendix A.
Because k is positive semi-definite, we can compute the embedding of the data Φt(X), and
induce a new diffusion metric on the data,
dtF (x, y) = ‖Φt(x)− Φt(y)‖2.
This, in turn, allows us to define f̂ : {xi} → R as an estimate to f(xi), where
f̂(x) = F (N dtF
(x)), where N 
dtF
(x) = {z ∈ {xi} : ‖Φt(x)− Φt(z)‖2 < }.
3.2 Interpolation and Leave Out Validation
The metric dtF and function estimate f̂ can easily be extended to new points z 6∈ {xi} not
in the training data. This is done by building an asymmetric affinity matrix to the training
data, which can be thought of as a reference set. The approach is an application of [10],
which we briefly outline here.
Let X be training data, and F defined on subsets of X. Let Z be testing points on which
F is not defined a priori. Define k : (X ∪ Z)×X → R+ to be
k(z, x) =
e−(z−x)ᵀW
−1
x (z−x)/σ2√
det(Wx)
, z ∈ Z ∪X, x ∈ X.
With the normalization matrices (D1)ii =
∑
j k(zi, xj) and (D2)ii =
∑
j k(zj , xi), we
set
A = D
−1/2
1 kD
−1/2
2 ,
and take the eigendecomposition of the small matrix A∗A = ΨΣΨ∗. This gives an embed-
ding of the reference points X. Then eigendecompsition of the entire set of points X ∪Z is
estimated by Φ = AΨ. The details of the extension algorithm can be found in Algorithm
2.
Algorithm 2 can be thought of as generating an optimized metric for a k-nearest neighbor
search. There could be better mechanisms of classification and regression for predicting f̂ ,
ranging from support vector machines in [1], to various types of linear regression, such as
Elastic Net from [16]. These choices are application and function specific, which is why we
remain with a simple nearest neighbor interpolation. The key is that the metric dtF agrees
with the intrinsic geometry of the data.
It is also important to run leave out validation of the algorithm to insure no overfitting
of the data. As the algorithm is semi-supervised and weights variables according to their
discriminatory power, it is possible to give high weight to features which are spuriously
correlated with the function. This makes it crucial to run N-fold cross validation of the
data to ensure that the predicted f̂(z) are good estimates to the true function.
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Algorithm 2 Nearest Neighbor Function Estimation
Required: Training points {xi}ni=1 ∈ Rm
Function F to be evaluated on E ⊂ {xi}
Testing points {zi}Ni=1 ∈ Rm
Result: Pointwise function estimate on testing points f̂(zi)
1. Build stable function weighted diffusion embedding of the features Φt(Y ) and a hier-
archical tree Y via Algorithm 1 using the training points {xi}ni=1
2. Build a function weighted diffusion embedding Φ̂t(X ∪Z) using the weighted embed-
ding via reference set algorithm (see Section 3.2)
3. For each testing point z, define the pointwise training neighborhood N 
dtF
(z) = {x ∈
{xi} : ‖Φt(x)− Φt(z)‖2 < } and function estimate
f̂(z) = F (N dtF
(z))
4 Localized Hazard Ratio Estimation
The aim of the construction of the metric dtF from Section 3 is to construct a metric that
differentiates level sets of the treatment risk. This implies that, in a neighborhood N(x),
we can assume that |(Y1(Z)−Y0(Z))− (Y1(X)−Y0(X))| < δ. This implies we can estimate
the local treatment effect α̂ from the model
λ(t|Z) = λ0(t)eTZY1(Z)+(1−TZ)Y0(Z) (3)
≈ λ0(t)eTZα+Y0(Z), (4)
for Z ∈ N(X). This approximation is because α = Y1(Z) − Y0(Z) does not vary more
than δ in N(X).
Now assume we fit the false model to simply estimate treatment effectiveness, which is nec-
essary given no knowledge of the model assumptions for Y0(Z) locally. What we can assume
is that, given Z ∈ N(X), Y0(Z) cannot vary too much within a small neighborhood.
There are two regimes in which we study this question of estimating α. In either situation,
we have a censoring model C ∼ q and observe an outcome W only if W ≤ C. When that’s
the case, we denote D = 1, with D = 0 otherwise.
If we only observe D (i.e. whether or not the patient had an outcome before leaving the
trial), then α is estimated through method of moments between the two treatment groups.
If we observe the actual outcome time t along with D, α is estimated through partial
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likelihood maximization. We provide results for both, with the stronger and more concrete
results coming for observation only of the binary outcome variable D.
In both settings, we assume that the patient risk over time is dictated by (4). We also
assume that there is some censoring model C for each patient, which is a random variable
independent of (4) that dictates when a patient decides to leave the trial, if they are still
alive.
4.1 Binary Observation of Outcome with Censoring
In this scenario, we only observe D for each patient. This means we know whether they had
an outcome before they left the trial, but not the time at which the outcome occurred.
To create an estimate α̂, we use a method of moments approach. That is, within the
neighborhood N(X), we look at the empirical estimate
1
|N(X) ∩ {TX = 1}|
 ∑
z∈N(X)∩{TX=1}
DX
− 1|N(X) ∩ {TX = 0}|
 ∑
z∈N(X)∩{TX=0}
DX
 . (5)
We borrow and modify results from [5] about small variation of misspecified models. For
notation, let
Π(X,TX) = P (D = 1|X,TX), Π(TX) = P (D = 1|TX) = EX(Π(X,TX)).
Theorem 2. Let the survival model satisfy (4), and the P (TX = 1) = p for 0 < p < 1.
Assume we use a method of moments estimation of the misspecified model
λ(t|X) = λ0(t)eTXα.
Let us further assume we only observe an indicator of outcome D.
Then the method of moments estimate converges at a rate of N−1/2Cp,α,Y0,λ0,q to α∗ for some
finite constant C that depends on p, α, λ0, the non-treated risk model, and the censoring
model. The estimate converges to α∗, which satisfies
α∗ = α+ log
(
Π(1)EX
[
Π(X, 0)e−Y0(X)
]
Π(0)EX
[
Π(X, 1)e−Y0(X)
]) .
Moreover, if Y0(X) is well approximated locally by its first order Taylor expansion Y0(Z) =
µ+ βX + O (ΣX) for small β, then we can reduce the log term to further show
|α∗ − α| < 1
2
β′ΣXβ · |R(α)−R(−α)|
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where
R(x) = 2φ′(x)/φ(x), for φ(x) = E(D|x),
is a constant that depends only on the size of α and the censoring model. Note also that
this implies α > 0 =⇒ α∗ > 0, α < 0 =⇒ α∗ < 0, and α = 0 =⇒ α∗ = 0.
The proof of Theorem 2 is in Appendix B.
4.2 Continuous Time to Outcome with Censoring
In this scenario, we observe D for each patient, as well as the actual outcome and/or
censoring time t. This means we know whether they had an outcome before they left the
trial, as well as the time that the outcome occurred. That time is an additional source
of information, given that we can now attempt to partially order all patients that had an
outcome, and ensure that people who were censored at time t are estimated to live at least
that long (if not longer).
To create an estimate α̂, we use partial likelihood maximization. That is, we construct the
log likelihood function
l(η) =
∑
Z
η(Z)− log ∑
Y ∈RZ
eη(Y )
 , (6)
where RZ = {Y : tY > tZ}, and η(Z) is the argument of the exponential evaluated for
patient Z. In the case of the misspecified model, the argument used is η(Z) = αTZ , and
the true model is η∗(Z) = αTZ + Y0(Z).
We borrow results from [5] about small variation of misspecified models, and [15] and [13]
about convergence rates. For notation, let
H(y|X,TX) = P (t > y|X,TX).
Theorem 3 ([5]; restated). Let the survival model satisfy (4), and the P (TX = 1) = p for
0 < p < 1. Assume we use a partial likelihood estimation of the misspecified model
λ(t|X) = λ0(t)eTXα. (7)
Let us further assume we observe both an indicator of the outcome D and an outcome/censoring
time t. Also, let T0 be the final time at which patients are observed (i.e. our censoring model
censors anyone that lives past time T0).
13
Then the partial likelihood estimate converges at a rate of N−1/2Cp,α,Y0,λ0,q to α∗ for some
finite constant C that depends on p, α, λ0, the non-treated risk model, and the censoring
model, as shown by [15] and [13]. The estimate converges to α∗, which satisfies∫ T0
0
E
[
H(y|X,TX)TXeαTX+Y0(X)
]
]λ0(y)dy
=
∫ T0
0
E
[
H(y|X,TX)TXeα∗TX
]
E
[
H(y|X,TX)eαTX+Y0(X)
]
E [H(y|X,TX)eα∗TX ] λ0(y)dy,
as shown by [5].
Moreover, if Y0(X) is well approximated locally by its first order Taylor expansion Y0(Z) =
µ+ βX + O ((ΣX)) for small β, then we can reduce the log term further to show
α∗ − α u 1
2
(β′ΣXβ)
E(l(2))E(TX l(3))− E(TX l(2))E(l(3))
[E(l(2))]2 − [E(TX l(2))]2
,
where l(k) is the kth derivative of the log likelihood (6) with respect to η.
Proof. The only part of Theorem 3 that is not restated from [5] is the convergence rate. [15]
shows that, given a correct model for Y0(X) as in (4), the partial likelihood maximization
estimate α̂ satisfies
N1/2(α̂− α)→ N (0,Σp,α,Y0,λ0,q),
where convergence is in distribution. Furthermore, [13] shows that the same rate of con-
vergence applies to a misspecified model (7), with the exception that α̂ converges to an a
priori unknown value α∗. The rest of the proof focuses on characterizing α∗ in terms of
known quantities, as done by [5].
5 Examples
5.1 Synthetic Randomized Drug Trial
We create a model of synthetic patients in a drug trial. The patient baseline model consists
of 9 dimensions of correlated information, where
xk ∈ [0, 1], x23i+1 + x23i+2 + x23i+3 = 1, for i ∈ {0, 1, 2}.
We note that this model choice is arbitrary, and was solely chosen to model a dependence
between patient features. The patients are randomly split into treatment A and treatment
B.
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The baseline hazard function for the patients is a Weibull distribution of the type
P (X < t) = e−λt
k
,
for λ = 2 and k = 1.2. If a patient is in treatment A, their outcome time tx is sampled from
the Weibull distribution. If a patient is in treatment B, their outcome time tx is sampled
from the Weibull distribution and then adjusted by tx 7→ txeβx . Any patient is censored if
tx > T for a fixed T .
The key behind this model is that βx is patient specific, and depends only on a subset of
the patient’s baseline information. Specifically,
βx = f(x1, x2, x3),
where f is displayed in Figure 3. Setting T = 2 and sup |eβx | = 3, about 10.5% of patients
have an outcome.
Figure 3:
A linear Cox proportional hazard model, by definition, is unable to recover the full spread
of βx. But beyond that, in this case a linear model fails to even recover the treatment group
as a significant factor in risk. See Table 1 for the regression coefficients.
Variable Name Treatment x1 x2 x3 x4 x5 x6 x7 x8 x9
Coefficeint 0.0597 -1.8517 -1.6500 -1.8440 -0.1797 -0.3245 -0.1619 -0.1127 0.0566 0.0954
p-value 0.3155 0.0001 0.0001 0.0001 0.3766 0.1087 0.4295 0.5826 0.7854 0.6450
Table 1:
Our algorithm on the other hand is able to recover both the geometry of the patients and an
estimate of the personalized hazard ratio βx. Figure 4 shows the recovered embedding of the
patients, and is colored by the estimate of βx. The model works for predictive personalized
hazards on new testing data, as well. We run repeated random sub-sampling validation on
the toy data by retaining 80% of the patients for training, and testing on the remaining
20%. This was iterated 100 times. The results are shown in Figure 5.
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(a) Predicted HR (b) Ground Truth HR
Figure 4:
Figure 5:
5.2 Models with Treatment Propensity
Let X ∼ N (0,Σ), with
Σi,j =

1, if i = j
0.5, if |i− j| = 1
0, otherwise
.
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The baseline hazard function is the same as in Section 5.1, and the personal hazard ratio
is
h(X) = X1 + 0.5X2 + 0.5X1X2 +XαX2.
However, unlike in the previous examples, Xα is not randomized across the population.
Instead,
P (Xα = 1) = P (wx < γ0 +Xγ),
where wx ∼ N (0, 1), γ0 = 0.5, and γ =
[
1 1 0 ... 0
]
.
Fraction Treated in Neighborhood Ground Truth h(X) Estimated h(X)
Figure 6: Black corresponds to points where > 80% of the points were from the same
treatment group, and thus removed due to lack of estimate precision.
We also consider a random model, in which Σ is a random symmetric positive definite matrix
with condition number less than 10, and the personal hazard ratio follows the form
h(X) =
∑
i
ξiXi +
∑
i,j
ηi,jXiXj +Xα
∑
i
νiXi +
∑
i,j
δi,jXiXj
 ,
where ξi and νi are sparse standard normal random variables which are non-zero with
probability 0.5. Also, ηi,j (resp. δi,j) are standard normal random variables which are
non-zero if and only if ξi and ξj (resp. νi and νj) are non-zero. Also, the probability that
a patient is treated is determined by
P (Xα = 1) = P (wx < γ0 +Xγ).
We run this model across 100 iterations, where we generate 2, 000 patients who’s base-
line hazard function is drawn from a Weibull distribution as in previous examples. The
patients are then censored such that  fraction of the patients have an outcome, where 
is a uniform random variable drawn from [1/3, 1]. We calculate the correlation between
the predicted personalized treatment effect f̂(x) and the ground truth treatment effect∑
i νiXi +
∑
i,j δi,jXiXj . Because of the propensity for treatment, we only estimate f̂(x)
in neighborhoods such that ≤ 80% of the patients are in the same treatment group. The
histogram of correlations is in Figure 7.
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Figure 7: Histogram of Correlations between predicted personalized treatment effect and
ground truth across 100 iterations.
5.3 Real World Data
We examine our algorithm on breast cancer data from the Rotterdam Tumor Bank []. The
Rotterdam tumor bank dataset contains records for 1,546 patients with node-positive breast
cancer, and nearly 90 percent of the patients have an observed outcome. Because this data
has no ground truth, we must use leave out cross-validation to validate the recommenda-
tions. We train the model on a random 80% of the patients, and test on 20%, and we
iterate this process 100 times. We then split the testing data into three groups, where σ(f)
is the standard deviation of treatment recommendations:
• Recommended: People with recommendation |f(x)| > c · σ(f) such that f(x) > 0
and Xα = 0 or f(x) < 0 and Xα = 1. These are people whose actions followed the
recommendation.
• Neutral: People with recommendation |f(x)| < c · σ(f). These are people without
a strong recommendation.
• Anti-Recommended: People with recommendation |f(x)| > c · σ(f) such that
f(x) < 0 and Xα = 0 or f(x) > 0 and Xα = 1. These are people whose actions went
against the recommendation.
We then plot the survival curves of the Recommended and Anti-Recommended groups in
Figure 8. Again, these were all testing samples in order to avoid over-fitting to the outcomes.
The group of testing data patients that followed the recommendations lived significantly
18
Treatment survival curves
Recommendation survival curves
Figure 8: Treatment recommendation on Rotterdam breast cancer testing data for c = 0.5.
longer than those that did not follow the recommendation, with a p-value of p = 0.00025
for the log-rank test of whether these curves are significantly different.
6 Conclusions and Future Work
This paper develops a method for building a data dependent metric ρ : X × X → R+
that is simultaneously learns the level sets of a function F . The method only needs to
evaluate F on various half spaces of the data, making it useful when F cannot be evaluated
pointwise. We develop a weighted tree distance to accomplish this, and develop feature
weights at multiple scales and locations in the data. Once ρ has been discovered, we can
do k nearest neighbor prediction for new points added to the data without knowledge of F
at the point.
This algorithm was designed with medical applications in mind, specifically building a local
cox proportional hazard model for patients in a dataset. The embedding created by ρ can
be used to characterize types of people that are hurt or helped by a drug, and even assign a
personalized treatment hazard score to new patients whose outcomes are unknown.
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A Proof of Theorem 1
We show k can be expressed as an integral over all ambient space via
k(x, y) =
∫
dz
exp{−(x− z)ᵀW−1x (x− z)/σ2}√
det(Wx)
exp{−(y − z)ᵀW−1y (y − z)/σ2}√
det(Wy)
.
We then use identities 8.1.7 and 8.1.8 from [11], which show the product of two gaussians
gives
C√
det(Wx +Wy)
exp
[−(x− y)ᵀ(Wx +Wy)−1(x− y)/σ2] · e−mᵀW−1m√
det(W )
.
where m and W are combinations of x, y, and z. Their exact forms are irrelevant, as the
right hand term is simply a normalized guassian that can be integrated out with respect to
z. Thus, after evaluating the integral, we are left with
k(x, y) = C · e
−(x−y)ᵀ(Wx+Wy)−1(x−y)/σ2√
det(Wx +Wy)
.
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Now, for any w(x) we can compute∫
dxdy w(x)w(y)k(x, y) =
∫
dxdy w(x)w(y)
∫
dz
exp{−(x− z)ᵀW−1x (x− z)/σ2}√
det(Wx)
exp{−(y − z)ᵀW−1y (y − z)/σ2}√
det(Wy)
=
∫
dz
(∫
dx w(x)
exp{−(x− z)ᵀW−1x (x− z)/σ2}√
det(Wx)
)(∫
dy w(y)
exp{−(y − z)ᵀW−1y (y − z)/σ2}√
det(Wy)
)
=
∫
dz
(∫
dx w(x)
exp{−(x− z)ᵀW−1x (x− z)/σ2}√
det(Wx)
)2
≥ 0.
B Proof of Theorem 2
Let the survival model satisfy
λ(t|X) = λ0(t)eTXα+Y0(X),
and the P (TX = 1) = p for 0 < p < 1. Assume we use likelihood estimation of the
misspecified model
λ(t|X) = λ0(t)eTXα.
Also, assume the trial is observed until time T0.
The rate of convergence of for the method of moments calculation (5) is a simple application
of the central limit theorem, as DX is a Bernoulli random variable whose probability is a
function of the number of samples P (TX = 1)N , and the rate of outcomes prior to censoring,
which is dictated by α, λ0, Y0 and the censoring model q. The rest of the proof focuses on
characterizing α∗ in terms of known quantities.
[5] show that the method of moments limit point α∗ satisfy
E
[
D − eα∗T
∫ T0
0
λ0(t)dt
]
= 0
E
[
TX
(
D − eα∗T
∫ T0
0
λ0(t)dt
)]
= 0
under the false model. Rearranging these equations and noting that
Π(X,TX) = e
αTX+Y0(X)E
[∫ T0
0
λ0(t)dt
∣∣∣∣X,TX] ,
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we arrive at the equations
pΠ(1) + (1− p)Π(0) = peα
∗
2
TXEX
[
Π(X, 1)e−
α
2
TX−Y0(X)
]
+ (1− p)e−α
∗
2
TXEX
[
Π(X, 0)e
α
2
TX−Y0(X)
]
pΠ(1)− (1− p)Π(0) = peα
∗
2
TXEX
[
Π(X, 1)e−
α
2
TX−Y0(X)
]
− (1− p)e−α
∗
2
TXEX
[
Π(X, 0)e
α
2
TX−Y0(X)
]
.
Solving these equations for α∗ yields the desired result.
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